{
    "name": "bisacodyl rectal",
    "comment": "OTC",
    "other_names": [
        "Fleet Bisacodyl Enema",
        "Fleet Bisacodyl Suppository"
    ],
    "classes": [
        "Laxatives",
        "Stimulant"
    ],
    "source": "https://reference.medscape.com/drug/fleet-bisacodyl-enema-suppository-bisacodyl-rectal-999325",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies in pregnant women",
            "Recommended that medical advice from a physician first be obtained for use during pregnancy",
            "No studies on effect of human fertility conducted"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Clinical data show that neither the active moiety of bisacodyl, BHPM (bis-(p-hydroxyphenyl)-pyridyl-2-methane), nor its glucuronides are excreted into milk of healthy lactating human females; thus, this drug can be used during breast-feeding "
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to drug or components",
                "Patients with ileus, intestinal obstruction, acute abdominal conditions like acute appendicitis, acute inflammatory bowel diseases, severe abdominal pain associated with nausea and vomiting",
                "Severe dehydration",
                "Hereditary conditions that may be incompatible with excipient (lactose or sucrose)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "For rectal use only",
                "Drug should not be taken on a continuous daily basis or for extended periods without investigating cause of constipation",
                "Prolonged excessive use may lead to fluid and electrolyte imbalance and hypokalemia",
                "Not for use in presence of abdominal pain, nausea, fever, or vomiting, or within two hours of another medicine since desired effect of other medicine may be reduced",
                "Intestinal loss of fluids can promote dehydration; symptoms may include thirst and oliguria",
                "In patients suffering from fluid loss where dehydration may be harmful (eg, renal insufficiency, elderly patients) drug should be discontinued and only be restarted under medical supervision",
                "Patients may experience hematochezia (blood in stool) that is generally mild and self-limiting",
                "Dizziness and/or syncope reported in patients who have taken this drug; details available for these cases suggest that events would be consistent with defecation syncope (or syncope attributable to straining at stool), or with a vasovagal response to abdominal pain related to constipation and not necessarily to administration of this drug itself",
                "The use of suppositories may lead to painful sensations and local irritation, especially in patients with anal fissures and ulcerative proctitis, and should be used in these conditions under medical advice or as directed by physician",
                "Stimulant laxatives including this drug do not help with weight loss",
                "Since extended use of any laxative can cause dependence for bowel function, do not take for more than one week unless directed by a health professional",
                "If used every day for a week does not result in a bowel movement, a doctor should be consulted immediately",
                "Children should not be given this drug without medical advice"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "sodium sulfate/?magnesium sulfate/potassium chloride",
            "description": {
                "common": "sodium sulfate/?magnesium sulfate/potassium chloride increases toxicity of bisacodyl rectal by Other (see comment). Avoid or Use Alternate Drug. \nComment: Coadministration of stimulant laxatives and sodium sulfate/magnesium sulfate/potassium chloride may increase the risk of mucosal ulceration or ischemic colitis."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "sodium sulfate/potassium sulfate/magnesium sulfate",
            "description": {
                "common": "sodium sulfate/potassium sulfate/magnesium sulfate increases toxicity of bisacodyl rectal by Other (see comment). Avoid or Use Alternate Drug. \nComment: Coadministration of stimulant laxatives and sodium sulfate/magnesium sulfate/potassium chloride may increase the risk of mucosal ulceration or ischemic colitis."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "deflazacort",
            "description": {
                "common": "bisacodyl rectal and deflazacort both decrease  serum potassium. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "potassium acid phosphate",
            "description": {
                "common": "bisacodyl rectal decreases levels of potassium acid phosphate by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "potassium chloride",
            "description": {
                "common": "bisacodyl rectal decreases levels of potassium chloride by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Abdominal cramping",
            "percent": null
        },
        {
            "name": "Excessive diarrhea",
            "percent": null
        },
        {
            "name": "Electrolyte and fluid imbalance",
            "percent": null
        },
        {
            "name": "Rectal burning",
            "percent": null
        },
        {
            "name": "Vertigo",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        }
    ]
}